MedPath

The Effectiveness of Transdiagnostic Cognitive-Behavioral Therapy Protocol on Subclinical Symptoms of Anxiety and Depression, Emotion Regulation, Resilience and Spiritual Health

Not Applicable
Conditions
Anxiety, Depression, Emotion Regulation, Resilience and Spiritual Health.
Psychological and behavioral factors associated with disorders or diseases classified elsewhere
Registration Number
IRCT20211223053494N4
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
56
Inclusion Criteria

having preclinical anxiety and depression symptoms based on the cut-off point of a score of 18 and above in the DASS-42 subscale and a score of 16 and above in the anxiety subscale of the DASS-42 scale,
Not suffering from specific or underlying physical diseases,
Not suffering from severe psychiatric disorders such as bipolar spectrum disorders, psychotic spectrum disorders, and cognitive disorders.
Not using drugs and alcohol in the last three months.
Absence of speech or hearing problems
Willingness to participate in research

Exclusion Criteria

absence of more than two sessions,
receiving another similar psychological intervention at the same time as the current research,
receiving cognitive-behavioral interventions for at least 8 sessions in the last 1 year,
receiving psychiatric drugs at the same time as the intervention or within a month before the intervention,
Lack of consent to continue the treatment during the intervention process,
Aggravation of the person's problems during the intervention and the need to provide another intervention

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cognitive Emotion Regulation Score (CERQ) in the Garnevsky Questionnaire, Craig Vaspinhaven. Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Cognitive Emotion Regulation Questionnaire (CERQ).;Depression, anxiety and stress score in Lovibond and Lovibond scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Depression- Anxiety- Stress Scale (DASS).
Secondary Outcome Measures
NameTimeMethod
Spiritual well-being score in Paloutzian and Ellison questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Spiritual well-being (SWB).;Cognitive flexibility score in Dennis scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Cognitive flexibility scale (CFI).;Connor and Davidson Resilience Scale (CD-RISC). Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Connor and Davidson Resilience Scale (CD-RISC).
© Copyright 2025. All Rights Reserved by MedPath